Autoimmune-related hearing loss

Autoimmune diseases can affect various organ systems in the body—including the sensitive hearing organ. In autoimmune hearing loss, the body's immune system mistakenly attacks the structures of the inner ear, which can lead to progressive hearing loss. This rare but serious condition is often overlooked or confused with other forms of hearing loss. However, early detection and targeted treatment are crucial to prevent permanent damage to hearing.

What is autoimmune hearing loss?

Autoimmune hearing loss is a specific form of hearing impairment in which the body's own immune system attacks the sensitive structures of the inner ear. Medically, this condition is referred to as autoimmune inner ear disease (AIED). While the immune system normally protects the body from harmful intruders, this disease causes a fatal malfunction: the body's defenses recognize its own tissue in the inner ear as foreign and attack it. This misguided immune response leads to chronic inflammation in the inner ear, which can damage the sensitive hair cells and other important structures. The exact mechanism that triggers this autoimmune reaction is not yet fully understood. However, scientists suspect that a process known as molecular mimicry may play a role, whereby the immune system confuses the body's own proteins with those of pathogens due to structural similarities. The disease is relatively rare, accounting for less than one percent of all cases of sensorineural hearing loss. Nevertheless, it is of great clinical importance, as it can lead to severe, irreversible hearing damage and even complete deafness if left untreated.

Primary and secondary forms of the disease

Medical professionals distinguish between two basic forms of autoimmune hearing loss. Primary autoimmune inner ear disease occurs when the autoimmune reaction affects only the hearing. This isolated form is particularly difficult to diagnose, as no other organ systems are affected and important diagnostic clues are therefore missing. However, the secondary form is more common, in which hearing loss occurs as a side effect of a systemic autoimmune disease. Approximately 15 to 30 percent of cases fall into this category. Systemic diseases such as Cogan's syndrome, Wegener's granulomatosis, rheumatoid arthritis, systemic lupus erythematosus, or Sjögren's syndrome can affect the inner ear. This distinction has important implications for diagnosis and treatment. In the secondary form, other symptoms such as joint pain, skin changes, or eye problems can provide valuable clues to the underlying disease and enable targeted therapy.

Recognizing characteristic symptoms

Fluctuating and progressive hearing loss

The most striking feature of autoimmune hearing loss is its characteristic progression. Unlike typical age-related hearing lossUnlike age-related hearing loss, which usually progresses gradually and symmetrically, autoimmune hearing loss often begins suddenly and affects only one ear. The hearing loss is typically sensorineural, meaning that it is caused by damage to the inner ear or auditory nerves. A particularly characteristic symptom is the fluctuating course of hearing loss. Hearing ability may temporarily improve, only to deteriorate again. These fluctuations can occur over days, weeks, or even months and clearly distinguish the condition from other forms of hearing loss. Many affected individuals report that their hearing is worse in the morning than in the evening or that their hearing ability changes depending on the weather. The hearing loss usually progresses over weeks or months and can then spread to the other ear. Without proper treatment, the condition can lead to severe hearing loss or even complete deafness.

Accompanying symptoms of the vestibular system

In about half of cases, autoimmune hearing loss is accompanied by disturbances of the balance system. This is because the balance organ (vestibular organ) is located in close anatomical proximity to the cochlea in the inner ear and is often affected by the autoimmune reaction at the same time. Vestibular symptoms can manifest as vertigo, unsteadiness, or general balance problems. Some patients also develop positional vertigo, which only occurs with certain head movements. These symptoms can significantly impair quality of life and lead to falls or other accidents. In addition, many affected individuals report tinnitus such as whistling or ringing (tinnitus) and a feeling of fullness in the ears. These symptoms may be permanent or fluctuate like the hearing loss itself.

Systemic autoimmune diseases as the cause

Cogan syndrome

Cogan syndrome is a rare systemic autoimmune disease that primarily affects the eyes and inner ear. The disease was first described in 1945 by American ophthalmologist David Cogan and is characterized by distinctive audiovestibular and ocular symptoms. The hearing symptoms of Cogan syndrome are similar to those of Meniere's disease: sudden, progressive sensorineural hearing loss, which often develops over one to three months and can lead to deafness. It is accompanied by dizziness, tinnitus, and a feeling of fullness in the ears. Eye symptoms include inflammation of the cornea (interstitial keratitis), which can lead to visual disturbances, sensitivity to light, and eye pain. In severe cases, Cogan's syndrome can also cause inflammation of the large blood vessels, especially the aorta. This vasculitis can result in life-threatening complications such as aortic insufficiency or aneurysms.

Granulomatosis with polyangiitis

Granulomatosis with polyangiitis (GPA), formerly known as Wegener's disease, is a systemic vasculitis that affects small and medium-sized blood vessels. The disease is characterized by the formation of granulomatous inflammation in the respiratory tract, kidneys, and other organs. Hearing loss in GPA is usually caused by involvement of the middle ear. The inflammation can lead to chronic middle ear infections, effusion in the tympanic cavity, or even perforation of the eardrum. In some cases, the inner ear is also directly affected, leading to sensorineural hearing loss. The diagnosis is often supported by other symptoms such as chronic sinusitis, nosebleeds, pneumonia, or kidney problems. Laboratory tests can detect specific antibodies (c-ANCA/PR3-ANCA) that are helpful for diagnosis.

Other relevant autoimmune diseases

Various other systemic autoimmune diseases can also lead to hearing problems. Sjögren's syndrome, a disease that primarily affects the salivary and lacrimal glands, is associated with an increased risk of hearing loss, tinnitus, and vertigo. Studies show that patients with Sjögren's syndrome have a 1.7-fold increased risk of gradual hearing loss. Systemic lupus erythematosus can lead to vascular damage in the inner ear through the formation of immune complexes. Rheumatoid arthritis, known for its joint involvement, can also affect hearing in rare cases, presumably through similar inflammatory mechanisms. Inflammatory bowel diseases such as Crohn's disease or ulcerative colitis have also been linked to hearing loss, although the exact mechanism is not yet fully understood.

Diagnostic challenges

Why diagnosis is difficult

The diagnosis of autoimmune inner ear disease poses considerable challenges for physicians. The main reason for this is that there is no specific diagnostic test that can definitively confirm the disease. The diagnosis is therefore typically a diagnosis of exclusion, in which other possible causes of hearing loss must be systematically eliminated. The rarity of the disease adds to the problem. Since AIED accounts for only a very small proportion of all cases of sensorineural hearing loss, many doctors do not immediately consider this possibility. Other, more common causes such as sudden hearing loss, acoustic neuroma, or age-related hearing loss are often considered first. Another problem is the variable symptoms. While some patients show classic fluctuating hearing loss, others may have atypical courses, which further complicates the diagnosis.

Audiological examinations

hearing loss. Autoimmune hearing loss typically manifests as sensorineural hearing loss, which is often asymmetrical. It is particularly important to document the progression over time of the Hearing loss symptomsRepeated hearing tests over a longer period of time can reveal the characteristic fluctuations that are crucial for diagnosis. Measuring speech intelligibility and otoacoustic emissions can also provide valuable information. Balance tests such as electronystagmography or caloric testing are particularly relevant if the patient complains of dizziness or balance problems.

Laboratory diagnostics and imaging

Blood tests play an important role in differential diagnosis. Although there are no specific markers for AIED, various laboratory values can provide indications of an autoimmune disease. These include general inflammation markers such as ESR and CRP, as well as specific autoantibodies such as antinuclear antibodies (ANA), rheumatoid factor, or ANCA antibodies. If certain systemic diseases are suspected, other specific antibodies are determined, such as anti-Ro/SSA and anti-La/SSB antibodies in Sjögren's syndrome or anti-dsDNA in systemic lupus erythematosus. Imaging techniques are essential to rule out other causes of hearing loss. An MRI of the brain and inner ear canals with contrast medium can reveal tumors such as acoustic neuromas, inflammatory changes, or vascular lesions. In some cases, a high-resolution CT scan of the temporal bone may also be useful to identify structural abnormalities.

Treatment approaches and therapy options

Drug therapy

The goal of drug treatment for autoimmune hearing loss is to suppress the excessive immune response and reduce inflammation in the inner ear. Corticosteroids are the first line of treatment. Prednisone or prednisolone are typically administered in high doses (1-2 mg/kg body weight) over several weeks, followed by a slow reduction in dosage. The response rate to corticosteroids is relatively high initially—about 70 percent of patients show improvement in hearing. However, long-term success is limited. Only about 14 percent of patients benefit permanently from steroid therapy. In most affected individuals, symptoms return after the steroid dose is reduced. If corticosteroids are ineffective or not tolerated, other immunosuppressive drugs are used. Methotrexate, originally a cancer drug, is used in low doses as an immunosuppressant and has proven effective in some patients. Other options include azathioprine, cyclophosphamide, or newer biologics such as TNF-alpha inhibitors.

Hearing aids and technical support

If drug therapy cannot adequately control hearing loss or if the hearing impairment is already too advanced, hearing aids are used for rehabilitation. In cases of mild to moderate hearing loss, modern hearing aids can significantly improve communication skills. In cases of severe hearing loss or deafness, a cochlear implant (CI) is often the only option for restoring hearing. Early implantation is important, as chronic inflammation in the inner ear can lead to ossification of the cochlea, which makes implantation technically more difficult. Interestingly, autoimmune-related inflammation can also affect the function of the implant after cochlear implantation. Fluctuating impedance values may occur, requiring more frequent adjustment of the speech processor. Accompanying immunosuppressive therapy can stabilize these fluctuations.

Treatment of accompanying symptoms

The treatment of vestibular symptoms often requires a multimodal approach. Acute vertigo can be treated with antivertiginosa, although these medications should only be used for a short period of time so as not to interfere with central compensation. Vestibular rehabilitation is an important component of therapy. Special balance exercises help the brain to compensate for the deficient information from the vestibular system. Positioning maneuvers can be helpful in cases of benign paroxysmal positional vertigo (BPPV).

Prognosis and long-term care

The long-term prognosis for autoimmune hearing loss varies greatly and depends on a number of factors. The most important factor is the timing of treatment—the earlier treatment begins, the better the prospects for stabilizing or even improving hearing. Patients with secondary autoimmune inner ear disease as part of a systemic autoimmune disease often require long-term immunosuppressive therapy. Treatment must be coordinated with the other affected organ systems, which requires close cooperation between different disciplines. Care should be provided on an interdisciplinary basis, involving ENT doctors, audiologists, rheumatologists, and other specialists as necessary. Regular check-ups are necessary to monitor the course of therapy and adjust treatment if necessary. Patient education also plays an important role. Those affected must be informed about the chronic nature of the disease and learn to recognize deterioration at an early stage so that they can react quickly. With appropriate therapy and professional care, many patients can lead fulfilling lives despite the challenges.